Insulet Corp (NAS:PODD)
$ 199.42 2.91 (1.48%) Market Cap: 13.97 Bil Enterprise Value: 14.41 Bil PE Ratio: 60.40 PB Ratio: 17.65 GF Score: 84/100

Insulet Corp at Robert W Baird Global Healthcare Conference Transcript

Sep 09, 2020 / 04:15PM GMT
Release Date Price: $212.44 (+3.85%)
Jeffrey D. Johnson
Robert W. Baird & Co. Incorporated, Research Division - Senior Research Analyst

All right. Good morning, good afternoon. Thank you for joining us. And I think we are live. So let's just get started. As many of you hopefully know, my name is Jeff Johnson. I'm the senior medical technology analyst at Baird. Our next presentation this afternoon is from Insulet, manufacturer of the proprietary and differentiated Omnipod tubeless insulin pump and insulin infusion set.

With us today from Insulet, we're pleased to have Executive Vice President, Chief Financial Officer and Treasurer, Wayde McMillan; Executive Vice President and Chief Commercial Officer, Bret Christensen. And she's not frozen on your screen, that's just a picture there of VP of Investor Relations, Deb Gordon.

So Wayde, I'm going to turn it over to you if you have any kind of opening remarks, and then we're just going to move right into Q&A.

Wayde D. McMillan
Insulet Corporation - Executive VP,CFO & Treasurer

Great. Thank you, Jeff, and good day,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot